Background/Aim: : Nephrotic syndrome (NS) is a potentially life-threatening state characterized
INTRODUCTION
NS is a clinical condition with a high morbidity and mortality that often leads to endstage renal failure with a high risk of cardiovascular complications due to severe hyperlipidemia (1) .
At present, no promising therapy is available due to lack of understanding of signaling culprits involved in the pathogenesis of nephrosis (2) . Fasudil is the first-generation Rho/ROCK inhibitor (6). It is the only Rho-kinase inhibitor practically available for long-term in vivo use (7).
Fasudil is mainly metabolized to an active metabolite (hydroxyfasudil) when administered in vivo, this metabolite still retains activity with more selective sustained action than its parent drug on Rho-kinase. It specifically inhibits RhoA kinase activity by competing for ATP binding. It is mainly excreted by the kidney (8).
The new biologically active angiotensin (1-7) (Ang1-7), a metabolite of angiotensin I and II, is considered the most pleiotropic component of the (RAS), reported as a counter regulatory mediator of Ang II (9). It was detected at different nephron segments at both cortical and medullary regions of the kidney, acting at both glomerular and tubular sites, producing complex renal effects (10).
AVE 0991 is the first nonpeptide orally active analog of Ang (1-7), Mas receptor agonist, which has a 10-fold higher affinity for Mas receptor than Ang (1-7), AVE 0991 mimics Ang (1-7) effects in several organs including kidneys (11).
At present, the concept of the RAS as a dual 
MATERIALS AND METHODS

Experimental Animals:
All animal experiments were undertaken with approval of Ethical Animal Research Committee of Tanta University. Fifty adult male albino rats weighing (200-250g) were purchased from Faculty of Science (Tanta University). The animals were housed at temperature 22±2 •C and 12 h dark/light cycle throughout the study.
Induction of experimental nephrotic syndrome:
NS was induced by single intravenous injection of 70 mg/kg body weight of the puromycin amino nucleoside (PAN) (Sigma) diluted in 0.9% saline (16). For consistency, day 0 was taken as the day of PAN injection. PAN -induced nephrosis is a well-described model of proteinuria, resembling the functional and morphological aspects of human minimal change disease or early stage focal segmental glomerulosclerosis (17).
Experimental Protocol:
Rats were randomly divided into five groups For the experiment, urine was collected from the day prior to PAN injection and on days 2 and 7 after injection. All treatment intervention started, after stabilization of proteinuria i.e. from the day (7) and continued until the end of experiment (till day 14), as an attempt to mimic the real clinical situation i.e. patients presented with some degree of injury, but not full blown renal damage.
Previous studies have shown that in (PAN) rat model, daily urinary protein excretion was dramatically elevated on day 5, reaching peak on day 9 and gradually return to normal level from day 15 -27 (2).
Biochemical assay:
At the end of the study period, rats in each group were individually housed in metabolic cage for 24h urine collection. Total urine volume was measured; one ml was collected from the 24 h urine sample, and used for measurement of total proteinuria and Creatinine clearance.
Collection of Blood Sample:
Rats were decapitated. Blood was collected and centrifuged at 1000 rpm and sera stored at -20°C till biochemical analysis. Level of TGF-β1 in the urine was assessed by ELISA according to method of Tsakas (26).
Sample of the urine were collected in metabolic cages and stored at -20ºC. Until refrigeration, 10 mL of commercial protease inhibitor cocktail (Sigma Aldrich) were added at urine sample.
Results were expressed as relative units of cytokine per mg of urinary creatinine.
Statistical analysis:
All values were expressed as mean ± SD.
Statistical analysis was performed by GraphPad
Prism software, release 4.0 (GraphPad Software, San Diego, CA). The data obtained from various groups were statistically analyzed using unpaired t test followed by one-way ANOVA. The P value < 0.05 was considered to be statistically significant. TGF-β1., Transgrowth factor -β1, C-RP.,c-reactive protein ,TNF-α., Tumor necrosis factor -α ª P < 0.05; versus control group. ᵇP < 0.05; versus PAN -induced nephrotic group All values are expressed as mean ± SD of 10 rats in each group. 
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DISCUSSION
The major findings of the present study can be 
